Lab On-Chip and Microarrays Market : By Product Type (Lab-On-A-Chips (PDMS Lab-On-A-Chip, Thermo Polymers Lab-On-A-Chip, Glass LAB-ON-A-CHIP, Silicon Lab-On-A-Chip, Paper Lab-On-A-Chip) Microarrays (DNA Microarrays, Tissue Microarrays, Protein Microarray, Others)), By End User (Biotechnology and Pharmaceutical Firms, Academic and Research Institutions, Hospitals and Diagnostic Centres) and Geography   

Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Lab On-Chip And Microarrays Market size is expected to reach USD x billion by 2028, growing at a CAGR of x% during forecast period 2022 to 2028. Lab on the chip an evolutionary device which integrates single or many laboratory functions on one integrated circuit commonly, a cSizhip. Lab-on-chip generally measures about few square centimetres and used to achieve automation and high through screening. The microarray is the most recent advances in the cancer research. Microarrays help to analyse plenty of samples which have already been recorded or new samples, it even helps to test the incidence of a particular marker in tutors. There are two types of microarrays, gene expression microarrays and tissue microarrays. The lab on-chip and microarrays market has very few and dominant players who are actively participating in research and development of the new products. Companies are launching the new products to increase the market share.   Key Developments: In November 2016, Abbott laboratories received CE mark for its innovative blood testing device i-STAT Alinity point of care system, a portable device that can perform and analyse largest menu of blood tests on a single device. Furthermore, companies are collaborating in the development of the new products. In March 2016, CombiMatrix Molecular Diagnostics (CMDX) and Array Genomics Inc. entered into the collaboration agreement to develop and market a series of comparative genomic hybridization (CGH) microarray products.

Lab On Chip And Microarrays Market Summary

Study Period

2023-29

Base Year

2022

CAGR

x%

Largest Market

North America

Fastest Growing Market

Europe
Lab On Chip And Microarrays Market Dynamics

Global lab on chip and microarrays market is mainly driven by the increase in the adaptation of lab on chip and microarrays in various research fields such as drug discovery, genomics, proteomics and others. In addition, increase in demand for personalized medicine and increase in prevalence rates of cancer that led to the demand for the development of R&D related to cancer diagnostics and treatment expected to boost the global lab on chip and microarrays market over the forecast period. However, a high cost of devices and stringent regulations for research on genomes are expected to hamper the market growth over the forecast period.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Lab On Chip And Microarrays Market Segmentation

By Product Type
  • Lab-On-A-Chips
    • PDMS Lab-On-A-Chip
    • Thermo Polymers Lab-On-A-Chip
    • Glass LAB-ON-A-CHIP
    • Silicon Lab-On-A-Chip
    • Paper Lab-On-A-Chip
  • Microarrays
    • DNA Microarrays
    • Tissue Microarrays
    • Protein Microarray
    • Others
By End-User
  • Biotechnology and Pharmaceutical Firms
  • Academic and Research Institutions
  • Hospitals and Diagnostic Centres

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

[urltag url='request-table-of-content']

  • Affymetrix Inc. (U.S.)
  • Abbott Laboratories (U.S.)
  • Agilent Technologies (U.S.)
  • Biomerieux SA (France)
  • Beckman Coulter Inc. (U.S.)
  • CombiMatrix Molecular Diagnostics (CombiMatrix Corp.) (U.S.)